"Clinical backing and low dosage forms are key market demands"
29 Jan 2020 | Bioiberica
Amid its new thyroid API launch, Bioiberica was highlighting that it is seeking to develop further products for both the pharma and nutraceutical markets, but its searching for partners to galvanize this plan. Speaking at CPhI Worldwide 2019, Jaime Reguant, Healthcare Director also notes that the key market demands now are low dosages and clinical backing.
More videos